Pancreaticoduodenectomy is the standard care for invasive ampullary adenocarcinomas. However, endoscopic snare papillectomy (ESP) might play a curative role in very selected patients. We studied a series of 15 patients with T1 ampullary adenocarcinoma who were treated by ESP alone and followed up for a mean of 29.6 ± 21.9 months (range 8 - 81 months). ESP was curative for eight patients (57.1 %). No tumor-related death was observed in patients with a cancer infiltration depth of ≤ 4 mm. According to this preliminary experience, we suggest that this measurable variable threshold should be considered as a possible basis for future large-scale studies. © Georg Thieme Verlag KG Stuttgart - New York.
Endoscopic snare papillectomy: A possible radical treatment for a subgroup of T1 ampullary adenocarcinomas / G., Petrone; R., Ricci; P., Familiari; F., Inzani; M., Matsuoka; M., Mutignani; DELLE FAVE, Gianfranco; G., Costamagna; G., Rindi. - In: ENDOSCOPY. - ISSN 0013-726X. - 45:5(2013), pp. 401-404. [10.1055/s-0032-1326213]
Endoscopic snare papillectomy: A possible radical treatment for a subgroup of T1 ampullary adenocarcinomas
DELLE FAVE, Gianfranco;
2013
Abstract
Pancreaticoduodenectomy is the standard care for invasive ampullary adenocarcinomas. However, endoscopic snare papillectomy (ESP) might play a curative role in very selected patients. We studied a series of 15 patients with T1 ampullary adenocarcinoma who were treated by ESP alone and followed up for a mean of 29.6 ± 21.9 months (range 8 - 81 months). ESP was curative for eight patients (57.1 %). No tumor-related death was observed in patients with a cancer infiltration depth of ≤ 4 mm. According to this preliminary experience, we suggest that this measurable variable threshold should be considered as a possible basis for future large-scale studies. © Georg Thieme Verlag KG Stuttgart - New York.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
